BARCLAYS PLC - AIMMUNE THERAPEUTICS INC ownership

AIMMUNE THERAPEUTICS INC's ticker is AIMT and the CUSIP is 00900T107. A total of 129 filers reported holding AIMMUNE THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.94 and the average weighting 0.8%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of AIMMUNE THERAPEUTICS INC
ValueSharesWeighting
Q3 2020$4,605,000
+253.4%
133,703
+71.5%
0.00%
+200.0%
Q2 2020$1,303,000
+2.9%
77,982
-11.1%
0.00%0.0%
Q1 2020$1,266,000
-53.9%
87,763
+6.9%
0.00%
-50.0%
Q4 2019$2,748,000
+126.7%
82,124
+41.8%
0.00%
+100.0%
Q3 2019$1,212,000
+49.6%
57,926
+48.9%
0.00%
Q2 2019$810,000
+145.5%
38,900
+163.8%
0.00%
Q1 2019$330,000
+478.9%
14,747
+520.9%
0.00%
Q4 2018$57,000
-97.7%
2,375
-97.3%
0.00%
-100.0%
Q3 2018$2,442,000
+1528.0%
89,528
+1514.3%
0.00%
Q2 2018$150,000
-80.6%
5,546
-77.2%
0.00%
-100.0%
Q1 2018$775,000
-91.9%
24,325
-90.3%
0.00%
-87.5%
Q4 2017$9,517,000
+592.6%
251,628
+353.7%
0.01%
+700.0%
Q3 2017$1,374,000
+45700.0%
55,463
+53229.8%
0.00%
Q2 2017$3,000
-97.3%
104
-98.0%
0.00%
Q1 2017$111,000
+29.1%
5,097
+19.6%
0.00%
Q4 2016$86,000
+1333.3%
4,262
+907.6%
0.00%
Q3 2016$6,0004230.00%
Other shareholders
AIMMUNE THERAPEUTICS INC shareholders Q1 2019
NameSharesValueWeighting ↓
Chicago Capital Management, LLC 414,500$14,280,00013.67%
Burrage Capital Management LLC 332,546$11,456,0009.04%
Penn Mutual Asset Management, LLC 158,783$5,470,0007.72%
First Trust Capital Management L.P. 525,598$18,107,0004.87%
GARDNER LEWIS ASSET MANAGEMENT L P 653,711$22,520,0004.08%
ALPINE ASSOCIATES MANAGEMENT INC. 2,075,100$71,488,0003.76%
S. MUOIO & CO. LLC 90,000$3,101,0003.52%
EQUITEC PROPRIETARY MARKETS, LLC 124,700$4,296,0003.27%
GABELLI & Co INVESTMENT ADVISERS, INC. 501,719$17,284,0003.11%
WATER ISLAND CAPITAL LLC 1,062,245$36,594,0003.11%
View complete list of AIMMUNE THERAPEUTICS INC shareholders